GlassScriptPhysician profile
Piyush B Patel
NPI 1629011283
$10,246.60
in general payments reported to CMS, 2019-2025
48 companies · $615 in 2025
The $615 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,876 · 2020: $1,322 · 2021: $1,515 · 2022: $1,113 · 2023: $1,161 · 2024: $644 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,419.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,464.30 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $1,150.56 | 2019-2025 | Farxiga, Breztri, Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $810.19 | 2021-2025 | |
| Glaxosmithkline, LLC. | $808.74 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Sunovion Pharmaceuticals INC. | $746.05 | 2019-2022 | |
| Lilly USA, LLC | $424.12 | 2020-2025 | Mounjaro, Zepbound, Amyvid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $410.29 | 2019-2025 | Jardiance |
| Pfizer INC. | $333.15 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $302.80 | 2019-2025 | Rexulti, Nuedexta |
| Novartis Pharmaceuticals Corporation | $295.59 | 2019-2025 | |
| Novo Nordisk INC | $234.46 | 2020-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $221.71 | 2020-2025 | |
| Sanofi-Aventis U.S. LLC | $177.30 | 2019-2022 | |
| Valeritas, INC. | $174.18 | 2019 | |
| Ardelyx, INC. | $169.76 | 2025 | Ibsrela |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Piyush Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.